|
|
 |
|
Total Number of Holdings (excluding cash): 48
| Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
6,940 |
$1,241,149.60 |
8.13% |
| AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
5,479 |
$1,145,932.85 |
7.51% |
| Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
43,330 |
$1,099,715.40 |
7.21% |
| Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
12,414 |
$1,050,969.24 |
6.89% |
| Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
19,208 |
$926,978.08 |
6.07% |
| Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
62,037 |
$660,694.05 |
4.33% |
| Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
5,009 |
$594,718.57 |
3.90% |
| Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
4,075 |
$566,384.25 |
3.71% |
| Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
1,859 |
$551,100.55 |
3.61% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
1,789 |
$548,292.72 |
3.59% |
| Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
3,424 |
$536,746.24 |
3.52% |
| Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
819 |
$484,037.19 |
3.17% |
| Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
3,989 |
$474,970.23 |
3.11% |
| Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
622 |
$438,783.68 |
2.88% |
| Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
23,419 |
$408,895.74 |
2.68% |
| Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
870 |
$405,176.40 |
2.66% |
| Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
1,987 |
$317,085.46 |
2.08% |
| Illumina, Inc. |
ILMN |
452327109 |
Biotechnology |
2,996 |
$301,996.80 |
1.98% |
| Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
7,821 |
$296,103.06 |
1.94% |
| Organon & Co. |
OGN |
68622V106 |
Pharmaceuticals |
27,775 |
$260,251.75 |
1.71% |
| Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
3,636 |
$258,628.68 |
1.69% |
| Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
1,811 |
$241,279.53 |
1.58% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
2,815 |
$163,157.40 |
1.07% |
| Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
5,110 |
$148,036.70 |
0.97% |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Biotechnology |
320 |
$146,659.20 |
0.96% |
| Amneal Pharmaceuticals, Inc. |
AMRX |
03168L105 |
Pharmaceuticals |
15,230 |
$143,314.30 |
0.94% |
| Insmed Incorporated |
INSM |
457669307 |
Biotechnology |
968 |
$125,307.60 |
0.82% |
| Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
5,203 |
$123,102.98 |
0.81% |
| Guardant Health, Inc. |
GH |
40131M109 |
Biotechnology |
1,855 |
$108,517.50 |
0.71% |
| ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
4,028 |
$100,458.32 |
0.66% |
| Catalyst Pharmaceuticals, Inc. |
CPRX |
14888U101 |
Biotechnology |
4,694 |
$95,475.96 |
0.63% |
| Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
610 |
$93,299.50 |
0.61% |
| Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
1,074 |
$92,578.80 |
0.61% |
| Corcept Therapeutics Inc. |
CORT |
218352102 |
Pharmaceuticals |
1,303 |
$91,731.20 |
0.60% |
| Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
1,402 |
$91,200.10 |
0.60% |
| Madrigal Pharmaceuticals, Inc. |
MDGL |
558868105 |
Biotechnology |
231 |
$90,473.46 |
0.59% |
| ADMA Biologics, Inc. |
ADMA |
000899104 |
Biotechnology |
4,817 |
$83,334.10 |
0.55% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
Biotechnology |
1,665 |
$78,255.00 |
0.51% |
| Akero Therapeutics, Inc. |
AKRO |
00973Y108 |
Biotechnology |
1,607 |
$77,055.65 |
0.50% |
| TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
2,624 |
$74,285.44 |
0.49% |
| Axsome Therapeutics, Inc. |
AXSM |
05464T104 |
Biotechnology |
619 |
$72,416.81 |
0.47% |
| PTC Therapeutics, Inc. |
PTCT |
69366J200 |
Biotechnology |
1,429 |
$69,806.65 |
0.46% |
| Scholar Rock Holding Corporation |
SRRK |
80706P103 |
Biotechnology |
2,034 |
$69,969.60 |
0.46% |
| Veracyte, Inc. |
VCYT |
92337F107 |
Biotechnology |
2,271 |
$66,971.79 |
0.44% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
165 |
$65,069.40 |
0.43% |
| Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
440 |
$64,178.40 |
0.42% |
| Vericel Corporation |
VCEL |
92346J108 |
Biotechnology |
1,539 |
$54,419.04 |
0.36% |
| US Dollar |
$USD |
|
Other |
45,500 |
$45,499.98 |
0.30% |
| Sarepta Therapeutics, Inc. |
SRPT |
803607100 |
Biotechnology |
740 |
$15,229.20 |
0.10% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|